Highlights from the CX 2019 session, Paclitaxel: The last word
Urmila Kerslake2019-09-06T16:04:24+01:00The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]
The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]
Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they […]
Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.
A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.
CX […]